Standout Papers
- Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy. (2017)
- Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma. (2017)
Citation Impact
Citing Papers
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
2021 Science
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Balanoposthitis caused by Pseudomonas aeruginosa co-producing metallo-β-lactamase and 16S rRNA methylase in children with hematological malignancies
2009
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Analysis of Restriction Fragment Length Polymorphism and Ribotyping of Multiresistant Stenotrophomonas maltophilia Isolated from Persisting Lung Infection in a Cystic Fibrosis Patient
1995
The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management
1994
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
A view on drug resistance in cancer
2019 StandoutNature
Phagocytosis checkpoints as new targets for cancer immunotherapy
2019
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients
2003
The biology and management of non-small cell lung cancer
2018 StandoutNature
Dissecting the mechanisms of immune checkpoint therapy
2020 Nobel
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Susceptibility of clinical isolates of Fusarium to antifungal drugs
1996
Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer
2007
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Cancer immunoediting and resistance to T cell-based immunotherapy
2018
Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials
2021
The immune contexture in cancer prognosis and treatment
2017 Standout
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
2016
Merkel cell carcinoma
2017
Interaction between microbiota and immunity in health and disease
2020 Standout
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
2023
Methods for in vitro evaluating antimicrobial activity: A review
2015 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
2018
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Stenotrophomonas maltophilia in cystic fibrosis: Incidence and prevalence
1998
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials
1997
Infections due to emerging and uncommon medically important fungal pathogens
2004
Bacteremia Due to Stenotrophomonas (Xanthomonas) maltophilia: A Prospective, Multicenter Study of 91 Episodes
1996
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
2015
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The gut microbiota influences anticancer immunosurveillance and general health
2018
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift
2019
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Macrophage M1/M2 polarization
2020 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Side-effects of checkpoint inhibitor-based combination therapy
2016
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
2017
Defining trained immunity and its role in health and disease
2020 Standout
Bacterial colonisation withXanthomonas maltophilia — A retrospective study in a cystic fibrosis patient population
1994
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
2018
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
2020
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System
2017
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia
1995
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods
1994
Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
2021
Peptide Antimicrobial Agents
2006 Standout
Recent updates on cancer immunotherapy
2018
Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead
2017
Use of Random Amplified Polymorphic DNA PCR To Examine Epidemiology of Stenotrophomonas maltophilia and Achromobacter ( Alcaligenes ) xylosoxidans from Patients with Cystic Fibrosis
2001
Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management
1997
Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro
1992
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy
1994
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin
1998
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method
1995
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem
1996
Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
2004
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
The Next Decade of Immune Checkpoint Therapy
2021 Nobel
Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma
2018
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy
2016
Therapeutic cancer vaccines
2015
Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin
1994
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin
1998
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media
2001
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Alexandre Reuben being referenced
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma
2016
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy
2015
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
2018
Monitoring immune responses in the tumor microenvironment
2016
Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever
1991
Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
2019 Nobel
Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy.
2017 StandoutNobel
Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method
1989
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.
2014
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
2020 Nobel
Interaction of molecular alterations with immune response in melanoma
2017
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents
1990
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma
2018